Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 18/20 | 0.56 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.56 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.56 |
| ▸ | STAT6 | P42226 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12085402 | 0.84 | SYK (0.55) | SYKAURKBKCNH2ZAP70 | |
| SCHEMBL12085420 | 0.81 | SYK (0.57) | SYKAURKBKCNH2ZAP70STAT6 | |
| SCHEMBL12085361 | 0.80 | SYK (0.57) | SYKAURKBKCNH2ZAP70STAT6 | |
| SCHEMBL2627318 | 0.77 | SYK (0.72) | SYKAURKBKCNH2ZAP70STAT6 | |
| SCHEMBL12085422 | 0.76 | SYK (0.60) | SYKAURKBKCNH2ZAP70 | |
| SCHEMBL13624692 | 0.76 | SYK (0.67) | SYKAURKBKCNH2ZAP70STAT6 | |
| SCHEMBL764111 | 0.75 | SYK (0.69) | SYKAURKBKCNH2ZAP70STAT6 | |
| SCHEMBL2385591 | 0.74 | SYK (0.69) | SYKAURKBKCNH2ZAP70STAT6 | |
| SCHEMBL12085331 | 0.74 | CAMK1D (0.62) | SYKAURKBKCNH2 | |
| SCHEMBL12085292 | 0.74 | SYK (0.66) | SYKAURKBKCNH2ZAP70 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9139581-B2 | Inhibitors of protein kinases | PORTOLA PHARMACEUTICALS, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| US-20130029944-A1 | INHIBITORS OF PROTEIN KINASES | PORTOLA PHARMACEUTICALS, INC. (US) | 2013-01-31 | — | — | US | disclosed |
| US-8258144-B2 | Inhibitors of protein kinases | PORTOLA PHARMACEUTICALS, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| US-20090298823-A1 | Inhibitors of protein kinases | PORTOLA PHARMACEUTICALS, INC. (US) | 2009-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130029944-A1 | INHIBITORS OF PROTEIN KINASES | SYK, BTK, JAK2 | SYK 1/4885AURKB 595/4885KCNH2 2573/4885 |
| US-20090298823-A1 | Inhibitors of protein kinases | SYK, BTK, JAK2 | SYK 1/4885AURKB 595/4885KCNH2 2573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.